Imagin Medical Inc. (IMEXF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -3.4 Million CAD | 8.38% |
| 2021 | -3.87 Million CAD | 11.25% |
| 2020 | -4.36 Million CAD | 2.48% |
| 2019 | -4.47 Million CAD | 43.95% |
| 2018 | -7.98 Million CAD | -419.34% |
| 2017 | -1.53 Million CAD | 31.87% |
| 2016 | -2.25 Million CAD | -458.23% |
| 2015 | -404.25 Thousand CAD | 28.17% |
| 2014 | -562.82 Thousand CAD | -0.55% |
| 2013 | -559.74 Thousand CAD | 12.37% |
| 2012 | -638.78 Thousand CAD | 35.39% |
| 2011 | -988.75 Thousand CAD | -62.0% |
| 2010 | -610.33 Thousand CAD | 14.15% |
| 2009 | -710.94 Thousand CAD | 84.74% |
| 2008 | -4.65 Million CAD | -110.81% |
| 2007 | -2.2 Million CAD | -55.0% |
| 2006 | -1.42 Million CAD | -5.22% |
| 2005 | -1.35 Million CAD | -912.61% |
| 2004 | -133.77 Thousand CAD | 74.28% |
| 2003 | -520.2 Thousand CAD | -212.36% |
| 2002 | -166.54 Thousand CAD | -5.96% |
| 2001 | -157.17 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q3 | -292.82 Thousand CAD | 66.4% |
| 2023 Q2 | -871.56 Thousand CAD | -30.24% |
| 2023 Q1 | -669.21 Thousand CAD | 39.08% |
| 2022 Q1 | -779.88 Thousand CAD | 41.96% |
| 2022 FY | -3.54 Million CAD | 8.38% |
| 2022 Q4 | -1.09 Million CAD | -25.84% |
| 2022 Q3 | -872.95 Thousand CAD | -9.44% |
| 2022 Q2 | -797.63 Thousand CAD | -2.28% |
| 2021 Q2 | -897.39 Thousand CAD | -36.25% |
| 2021 Q1 | -658.65 Thousand CAD | 4.0% |
| 2021 FY | -3.87 Million CAD | 11.25% |
| 2021 Q4 | -1.34 Million CAD | -38.65% |
| 2021 Q3 | -969.23 Thousand CAD | -8.01% |
| 2020 Q4 | -686.07 Thousand CAD | -18.67% |
| 2020 FY | -4.36 Million CAD | 2.48% |
| 2020 Q1 | -1.23 Million CAD | 6.65% |
| 2020 Q2 | -1.86 Million CAD | -50.8% |
| 2020 Q3 | -578.15 Thousand CAD | 68.99% |
| 2019 Q1 | -1 Million CAD | 54.28% |
| 2019 FY | -4.47 Million CAD | 43.95% |
| 2019 Q4 | -1.32 Million CAD | -11.75% |
| 2019 Q3 | -1.18 Million CAD | -24.61% |
| 2019 Q2 | -950.94 Thousand CAD | 5.81% |
| 2018 Q4 | -2.2 Million CAD | -24.96% |
| 2018 Q3 | -1.76 Million CAD | 35.2% |
| 2018 FY | -7.98 Million CAD | -419.34% |
| 2018 Q2 | -2.72 Million CAD | -112.03% |
| 2018 Q1 | -1.28 Million CAD | -244.07% |
| 2017 Q3 | -297.62 Thousand CAD | 21.98% |
| 2017 FY | -1.53 Million CAD | 31.87% |
| 2017 Q4 | -373.8 Thousand CAD | -25.6% |
| 2017 Q2 | -381.49 Thousand CAD | 21.28% |
| 2017 Q1 | -484.63 Thousand CAD | 24.9% |
| 2016 Q1 | -139.56 Thousand CAD | -22.98% |
| 2016 FY | -2.25 Million CAD | -458.23% |
| 2016 Q4 | -645.3 Thousand CAD | -0.25% |
| 2016 Q3 | -643.66 Thousand CAD | 28.69% |
| 2016 Q2 | -902.62 Thousand CAD | -546.74% |
| 2015 Q2 | -100.78 Thousand CAD | 4.93% |
| 2015 Q4 | -113.48 Thousand CAD | -35.97% |
| 2015 Q3 | -83.46 Thousand CAD | 17.19% |
| 2015 FY | -404.25 Thousand CAD | 28.17% |
| 2015 Q1 | -106.01 Thousand CAD | 21.51% |
| 2014 Q1 | -92.3 Thousand CAD | 32.39% |
| 2014 FY | -562.82 Thousand CAD | -0.55% |
| 2014 Q2 | -102.32 Thousand CAD | -10.86% |
| 2014 Q4 | -135.06 Thousand CAD | 42.13% |
| 2014 Q3 | -233.38 Thousand CAD | -128.08% |
| 2013 Q1 | -143.07 Thousand CAD | -0.21% |
| 2013 FY | -559.74 Thousand CAD | 12.37% |
| 2013 Q4 | -136.51 Thousand CAD | 8.12% |
| 2013 Q3 | -148.57 Thousand CAD | -12.92% |
| 2013 Q2 | -131.57 Thousand CAD | 8.04% |
| 2012 Q4 | -142.78 Thousand CAD | 22.33% |
| 2012 Q3 | -183.84 Thousand CAD | 4.38% |
| 2012 FY | -638.78 Thousand CAD | 35.39% |
| 2012 Q2 | -192.26 Thousand CAD | -60.36% |
| 2012 Q1 | -119.89 Thousand CAD | 26.52% |
| 2011 Q3 | -577.61 Thousand CAD | -346.12% |
| 2011 FY | -988.75 Thousand CAD | -62.0% |
| 2011 Q4 | -163.17 Thousand CAD | 71.75% |
| 2011 Q1 | -118.48 Thousand CAD | 86.74% |
| 2011 Q2 | -129.47 Thousand CAD | -9.28% |
| 2010 Q2 | -132.99 Thousand CAD | 32.91% |
| 2010 Q3 | 336.43 Thousand CAD | 352.96% |
| 2010 Q4 | -893.84 Thousand CAD | -365.68% |
| 2010 Q1 | -198.24 Thousand CAD | 28.63% |
| 2010 FY | -610.33 Thousand CAD | 14.15% |
| 2009 FY | -710.94 Thousand CAD | 84.74% |
| 2009 Q4 | -277.77 Thousand CAD | -93.08% |
| 2009 Q3 | -143.86 Thousand CAD | 4.98% |
| 2009 Q1 | 368.07 Thousand CAD | 228.76% |
| 2009 Q2 | -151.39 Thousand CAD | -141.13% |
| 2008 Q2 | -1.17 Million CAD | -222.67% |
| 2008 FY | -4.65 Million CAD | -110.81% |
| 2008 Q4 | -285.85 Thousand CAD | 89.89% |
| 2008 Q3 | -2.82 Million CAD | -139.87% |
| 2008 Q1 | -365.31 Thousand CAD | -306.95% |
| 2007 FY | -2.2 Million CAD | -55.0% |
| 2007 Q1 | -279.17 Thousand CAD | 0.2% |
| 2007 Q3 | -218.77 Thousand CAD | 86.51% |
| 2007 Q4 | -89.76 Thousand CAD | 58.97% |
| 2007 Q2 | -1.62 Million CAD | -480.84% |
| 2006 Q1 | -132.25 Thousand CAD | 70.61% |
| 2006 Q2 | -342.87 Thousand CAD | -159.25% |
| 2006 Q3 | -670.47 Thousand CAD | -95.54% |
| 2006 Q4 | -279.74 Thousand CAD | 58.28% |
| 2006 FY | -1.42 Million CAD | -5.22% |
| 2005 Q3 | -424.08 Thousand CAD | -400.95% |
| 2005 Q4 | -450.05 Thousand CAD | -6.12% |
| 2005 Q2 | -84.65 Thousand CAD | 78.61% |
| 2005 Q1 | -395.74 Thousand CAD | -997.65% |
| 2005 FY | -1.35 Million CAD | -912.61% |
| 2004 Q4 | -36.05 Thousand CAD | 8.21% |
| 2004 Q1 | -25.9 Thousand CAD | 93.75% |
| 2004 Q3 | -39.27 Thousand CAD | -20.01% |
| 2004 Q2 | -32.72 Thousand CAD | -26.35% |
| 2004 FY | -133.77 Thousand CAD | 74.28% |
| 2003 Q1 | -32.1 Thousand CAD | 20.88% |
| 2003 FY | -520.2 Thousand CAD | -212.36% |
| 2003 Q2 | -35.57 Thousand CAD | -10.81% |
| 2003 Q4 | -414.15 Thousand CAD | -962.6% |
| 2003 Q3 | -38.97 Thousand CAD | -9.56% |
| 2002 Q3 | -39.86 Thousand CAD | 13.21% |
| 2002 Q4 | -40.57 Thousand CAD | -1.8% |
| 2002 FY | -166.54 Thousand CAD | -5.96% |
| 2002 Q1 | -40.14 Thousand CAD | 0.0% |
| 2002 Q2 | -45.92 Thousand CAD | -14.41% |
| 2001 FY | -157.17 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AVITA Medical, Inc. | -40.4 Million USD | 91.58% |
| Manhattan Scientifics, Inc. | -703 Thousand USD | -383.885% |
| Össur hf. | 87.46 Million USD | 103.889% |
| QHSLab, Inc. | -240.15 Thousand USD | -1316.448% |
| Wellstar International, Inc. | -1.79 Million USD | -89.543% |
| Össur hf. | 87.46 Million USD | 103.889% |
| CVR Medical Corp. | - USD | Infinity% |
| Bionovate Technologies Corp | - USD | Infinity% |
| Escalon Medical Corp. | -104.47 Thousand USD | -3155.976% |
| Aurora Spine Corporation | -446.19 Thousand USD | -662.381% |
| BrainsWay Ltd. | -4.92 Million USD | 30.958% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | -1140.188% |
| Hamilton Thorne Ltd. | 277.99 Thousand USD | 1323.651% |
| Vivos Inc. | -2.79 Million USD | -21.788% |
| Kelyniam Global, Inc. | -239.16 Thousand USD | -1322.323% |
| REMSleep Holdings, Inc. | -1.77 Million USD | -92.009% |
| Zecotek Photonics Inc. | -3.65 Million USD | 6.975% |
| Avitar, Inc. | 2.73 Million USD | 224.477% |
| Nanomix Corporation | -8.43 Million USD | 59.682% |
| EKF Diagnostics Holdings plc | 2.08 Million USD | 263.465% |
| Theraclion SA | -3.48 Million USD | 2.275% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Positron Corporation | -1.36 Million USD | -149.988% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.06 Million USD | -64.737% |
| Lombard Medical, Inc. | -29.33 Million USD | 88.404% |
| ALR Technologies Inc. | -2.94 Million USD | -15.456% |
| Stratec SE | 25.26 Million USD | 113.462% |
| Vycor Medical, Inc. | 40.19 Thousand USD | 8563.868% |
| Heart Tronics, Inc. | 14.46 Million USD | 123.525% |
| MicroPort Scientific Corporation | -516.16 Million USD | 99.341% |
| VMS Rehab Systems, Inc. | -68.66 USD | -4954331.984% |
| NewCardio, Inc. | -9.45 Million USD | 64.038% |
| Guided Therapeutics, Inc. | -3.45 Million USD | 1.599% |
| Ingen Technologies, Inc. | -1.61 Million USD | -110.81% |
| Odyssey Group International, Inc. | 14.26 Million USD | 123.853% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -797.772% |
| Wellness Center USA, Inc. | -707.02 Thousand USD | -381.128% |
| SANUWAVE Health, Inc. | -540 Thousand USD | -529.947% |
| IR-Med Inc. | -4.91 Million USD | 30.733% |
| Perimeter Medical Imaging AI, Inc. | -20.72 Million USD | 83.59% |
| Polarean Imaging plc | -12.55 Million USD | 72.908% |
| United American Healthcare Corporation | -67 Thousand USD | -4977.184% |
| ECGI Holdings, Inc. | -407.48 Thousand USD | -734.817% |
| Nu-Med Plus, Inc. | -120.52 Thousand USD | -2722.389% |
| Capital Group Holdings, Inc. | -634.68 Thousand USD | -435.966% |
| ADM Tronics Unlimited, Inc. | -601.52 Thousand USD | -465.519% |
| Medical Supply International USA, Inc. | 438.18 Thousand USD | 876.328% |
| Urologix, Inc. | -6.93 Million USD | 50.913% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.26 Million USD | -169.265% |
| Nexeon MedSystems Inc. | -6.26 Million USD | 45.703% |
| SS Innovations International, Inc. | -20.66 Million USD | 83.541% |
| Qualis Innovations, Inc. | -230.24 Thousand USD | -1377.458% |
| Smith & Nephew plc | 425 Million USD | 100.8% |
| NIOX Group Plc | 4.6 Million USD | 173.95% |
| Fuse Medical, Inc. | 383.82 Thousand USD | 986.278% |
| Broncus Holding Corporation | -33.22 Million USD | 89.76% |
| Brain Scientific Inc. | -9.6 Million USD | 64.596% |
| Pressure BioSciences, Inc. | -9.5 Million USD | 64.205% |
| Health Logic Interactive Inc. | -60.69 Thousand USD | -5504.232% |